Table III.
Numbers of patients with or without changes of interleukin (IL)-17 and IL-23 from baseline to week 26
IL-17A | IL-23 | |||||
---|---|---|---|---|---|---|
Decrease n (%) | No change n (%) | Increase n (%) | Decrease n (%) | No change n (%) | Increase n (%) | |
Herring roe oil, week 26, n = 29 | 16 (55) | 0 (0) | 13 (45) | 10 (34) | 17 (59) | 2 (7) |
Placebo, week 26, n = 32 | 13 (41) | 1 (3) | 18 (56) | 8 (25) | 17 (53) | 7 (22) |